Market revenue in 2023 | USD 48.4 million |
Market revenue in 2030 | USD 85.9 million |
Growth rate | 8.5% (CAGR from 2023 to 2030) |
Largest segment | Device |
Fastest growing segment | Software |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Software, Device, Storage Systems |
Key market players worldwide | Danaher Corp, Hamamatsu Photonics KK, Koninklijke Philips NV, Olympus Corp, Roche Holding AG ADR, McCormick & Co Inc Registered Shs Non Vtg, Inspire Medical Systems Inc, PHC Holdings Corp, Huron Consulting Group Inc, CellaVision AB Bearer Shs, IBEX Ltd, Morphic Holding Inc, Nuvation Bio Inc Ordinary Shares - Class A |
Device was the largest segment with a revenue share of 52.27% in 2023. Horizon Databook has segmented the UK digital pathology market based on software, device, storage systems covering the revenue growth of each sub-segment from 2018 to 2030.
The UK digital pathology market is expected to witness remunerative growth opportunities over the coming years. The growth can be attributed to growing preference for digital pathology as a result of associated benefits.
According to Cancer Research UK, cancer incidence was found to be approximately 363,484 cases in the UK every year, which mostly affects the population aged 85-89 years and above. More than half of the new cases were of prostate, breast, bowel, or lung cancer.
Initiatives undertaken by organizations such as the National Pathology Programme by the NHS England that aims for innovation and digitization in pathology. Such initiatives are undertaken to prevent premature mortality through early diagnosis as well as support clinical teams to interpret test results for patient efficiently.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account